Completed OBSERVATIONAL NCT00318578

Prognosis Factors Associated With Convulsive Status Epilepticus in Adults

Prognosis Factors Associated With Convulsive Status Epilepticus in Adults: A Multicenter Cohort Study

Sponsor: Versailles Hospital

Updated 7 times since 2017 Last updated: Aug 13, 2007 Started: Mar 31, 2005 Completion: Jan 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00318578, this observational or N/A phase trial focuses on Status Epilepticus and remains completed. Sponsored by Versailles Hospital, it has been updated 7 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Mar 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Versailles Hospital

Data source: Versailles Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Abbeville, France , Annonay, France , Argenteuil, France , Aulnay-sous-Bois, France , Cergy-Pontoise, France , Chartres, France , Châlons-en-Champagne, France , Clamart, France , Clermont-Ferrand, France , Compiègne, France and 21 more locations